Matches in Wikidata for { <http://www.wikidata.org/entity/Q86186920> ?p ?o ?g. }
Showing items 1 to 44 of
44
with 100 items per page.
- Q86186920 description "artículu científicu espublizáu en febreru de 2013" @default.
- Q86186920 description "im Februar 2013 veröffentlichter wissenschaftlicher Artikel" @default.
- Q86186920 description "scientific article published on 22 February 2013" @default.
- Q86186920 description "wetenschappelijk artikel" @default.
- Q86186920 description "наукова стаття, опублікована в лютому 2013" @default.
- Q86186920 name "Infliximab-related malignant melanoma and cranial nerves IX and XII palsy secondary to IFN-α2b therapy" @default.
- Q86186920 name "Infliximab-related malignant melanoma and cranial nerves IX and XII palsy secondary to IFN-α2b therapy" @default.
- Q86186920 type Item @default.
- Q86186920 label "Infliximab-related malignant melanoma and cranial nerves IX and XII palsy secondary to IFN-α2b therapy" @default.
- Q86186920 label "Infliximab-related malignant melanoma and cranial nerves IX and XII palsy secondary to IFN-α2b therapy" @default.
- Q86186920 prefLabel "Infliximab-related malignant melanoma and cranial nerves IX and XII palsy secondary to IFN-α2b therapy" @default.
- Q86186920 prefLabel "Infliximab-related malignant melanoma and cranial nerves IX and XII palsy secondary to IFN-α2b therapy" @default.
- Q86186920 P1433 Q86186920-2290BA41-80FF-40C3-9148-ACB9A715C389 @default.
- Q86186920 P1476 Q86186920-06B7C67D-304C-4078-8E5C-95A6F57E0CF4 @default.
- Q86186920 P2093 Q86186920-0FBE8612-6E59-4AE9-84E0-5D25DB5ACBC2 @default.
- Q86186920 P2093 Q86186920-2D5BAB7C-D390-4994-B703-A46F33CC3825 @default.
- Q86186920 P2093 Q86186920-3A3EF6D5-0A87-4EFD-976A-4A2AB1765B6A @default.
- Q86186920 P2093 Q86186920-5DBD5411-ED46-4E62-A7B1-13B9780F36C6 @default.
- Q86186920 P2093 Q86186920-9FACA972-478B-4754-ACD7-A1EFC340C9C8 @default.
- Q86186920 P2093 Q86186920-A56F50C1-ADEF-433C-95BB-227D6D86F461 @default.
- Q86186920 P304 Q86186920-8C732455-9E62-4FDB-9A87-1142E3B2CDE8 @default.
- Q86186920 P31 Q86186920-2715F3AA-7D04-473B-967D-E384D68F393C @default.
- Q86186920 P356 Q86186920-952836FB-455A-43CA-8F69-AD067C3FAB10 @default.
- Q86186920 P433 Q86186920-4316D534-DA34-4E78-AC78-0594243ECF5D @default.
- Q86186920 P478 Q86186920-D57256E7-2874-4B5D-A33D-A54BF51EE429 @default.
- Q86186920 P577 Q86186920-C998C41E-B240-4F1D-8483-CCC7B0FB58A2 @default.
- Q86186920 P698 Q86186920-83A676B9-769B-4183-B61A-36B24ED2DAF1 @default.
- Q86186920 P356 J.1365-4632.2011.05452.X @default.
- Q86186920 P698 23432398 @default.
- Q86186920 P1433 Q15752742 @default.
- Q86186920 P1476 "Infliximab-related malignant melanoma and cranial nerves IX and XII palsy secondary to IFN-α2b therapy" @default.
- Q86186920 P2093 "Emilia Fernández-López" @default.
- Q86186920 P2093 "Javier Cañueto" @default.
- Q86186920 P2093 "José M Mir-Bonafé" @default.
- Q86186920 P2093 "María Gil-Melcón" @default.
- Q86186920 P2093 "Pablo de Unamuno-Pérez" @default.
- Q86186920 P2093 "Rocío García-Domínguez" @default.
- Q86186920 P304 "1613-1615" @default.
- Q86186920 P31 Q13442814 @default.
- Q86186920 P356 "10.1111/J.1365-4632.2011.05452.X" @default.
- Q86186920 P433 "12" @default.
- Q86186920 P478 "52" @default.
- Q86186920 P577 "2013-02-22T00:00:00Z" @default.
- Q86186920 P698 "23432398" @default.